Accession Number: | 0001179110-19-001838 |
Date: | 2019-02-11 |
Issuer: | MOMENTA PHARMACEUTICALS INC (MNTA) |
Original Submission Date: |
CARVAJAL ALEJANDRA
C/O MOMENTA PHARMACEUTICALS, INC.
301 BINNEY STREET
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 12.76 | 2019-02-11 | deemed execution date | A | 92,000 (a) | 2029-02-11 | common stock 92,000 | $12.76 | 92,000 | direct |
ID | footnote |
---|---|
f1 | represents options granted by the issuer pursuant to the issuer's 2013 incentive award plan, as amended and restated. |
f2 | the stock option will vest and become exercisable with respect to 23,000 shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years. all vesting is subject to alejandra carvajal's continued service to the company through the applicable vesting date. |